KCNB1 | Potassium voltage-gated channel, Shab-related subfamily, member 1 | FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
KCTD8 | Potassium channel tetramerization domain containing 8 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
KHDRBS2 | KH domain containing, RNA binding, signal transduction associated 2 | Predicted intracellular proteins
| | | | | Tissue enhanced |
KIAA1107 | KIAA1107 | Predicted intracellular proteins
| | | | | Tissue enhanced |
KIAA1467 | KIAA1467 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
KLHL35 | Kelch-like family member 35 | Predicted intracellular proteins
| | | | | Tissue enhanced |
KLK6 | Kallikrein-related peptidase 6 | Cancer-related genes Enzymes Mitochondrial proteins Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
KLRC3 | Killer cell lectin-like receptor subfamily C, member 3 | Predicted membrane proteins
| | | | | Tissue enhanced |
L1CAM | L1 cell adhesion molecule | CD markers Disease related genes Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
LAMP5 | Lysosomal-associated membrane protein family, member 5 | Predicted membrane proteins
| | | | | Tissue enhanced |
LRP4 | Low density lipoprotein receptor-related protein 4 | Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
LRRTM1 | Leucine rich repeat transmembrane neuronal 1 | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
MAP1B | Microtubule-associated protein 1B | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
MAP6 | Microtubule-associated protein 6 | Predicted intracellular proteins
| | | | | Tissue enhanced |
MAPK4 | Mitogen-activated protein kinase 4 | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
MAPT | Microtubule-associated protein tau | Candidate cardiovascular disease genes Disease related genes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
NAP1L2 | Nucleosome assembly protein 1-like 2 | Predicted intracellular proteins
| | | | | Tissue enhanced |
NBEA | Neurobeachin | Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
NCAM1 | Neural cell adhesion molecule 1 | Cancer-related genes CD markers Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
NCS1 | Neuronal calcium sensor 1 | Predicted intracellular proteins
| | | | | Tissue enhanced |
NECAB2 | N-terminal EF-hand calcium binding protein 2 | Predicted intracellular proteins
| | | | | Tissue enhanced |
NEFM | Neurofilament, medium polypeptide | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
NGB | Neuroglobin | Predicted intracellular proteins
| | | | | Tissue enhanced |
NKG2-E | Uncharacterized protein {ECO:0000313|Ensembl:ENSP00000437563} | Predicted membrane proteins
| | | | | Tissue enhanced |
NLGN2 | Neuroligin 2 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
NOVA1 | Neuro-oncological ventral antigen 1 | Predicted intracellular proteins
| | | | | Tissue enhanced |
NOVA2 | Neuro-oncological ventral antigen 2 | Predicted intracellular proteins
| | | | | Tissue enhanced |
NPTX2 | Neuronal pentraxin II | Predicted secreted proteins
| | | | | Tissue enhanced |
NTM | Neurotrimin | Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
NTRK2 | Neurotrophic tyrosine kinase, receptor, type 2 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
NTRK3 | Neurotrophic tyrosine kinase, receptor, type 3 | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
NUAK1 | NUAK family, SNF1-like kinase, 1 | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
NYAP1 | Neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adaptor 1 | Predicted intracellular proteins
| | | | | Tissue enhanced |
P2RY12 | Purinergic receptor P2Y, G-protein coupled, 12 | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
PCSK1N | Proprotein convertase subtilisin/kexin type 1 inhibitor | Predicted secreted proteins
| | | | | Tissue enhanced |
PLXNB3 | Plexin B3 | Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
PNMAL1 | Paraneoplastic Ma antigen family-like 1 | Predicted intracellular proteins
| | | | | Tissue enhanced |
PPFIA3 | Protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 3 | Predicted intracellular proteins
| | | | | Tissue enhanced |
PPFIA4 | Protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 4 | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
PPM1E | Protein phosphatase, Mg2+/Mn2+ dependent, 1E | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
PSAT1 | Phosphoserine aminotransferase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
PTPRN2 | Protein tyrosine phosphatase, receptor type, N polypeptide 2 | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
PTPRR | Protein tyrosine phosphatase, receptor type, R | Enzymes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
RASGRF2 | Ras protein-specific guanine nucleotide-releasing factor 2 | Predicted intracellular proteins RAS pathway related proteins
| | | | | Tissue enhanced |
RGMA | Repulsive guidance molecule family member a | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
RNF112 | Ring finger protein 112 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
RNF157 | Ring finger protein 157 | Predicted intracellular proteins
| | | | | Tissue enhanced |
RNF165 | Ring finger protein 165 | Predicted intracellular proteins
| | | | | Tissue enhanced |
RNF208 | Ring finger protein 208 | Predicted intracellular proteins
| | | | | Tissue enhanced |
RNFT2 | Ring finger protein, transmembrane 2 | Predicted membrane proteins
| | | | | Tissue enhanced |